MSTR heads into the back half of September with an unusual split: short sellers are building positions against a stock that analysts are racing to upgrade.
The core tension is straightforward. The stock dropped 5.4% on Tuesday to $129.60, extending a weekly loss of just over 5%. Yet over the past month it is up nearly 40%, and the analyst community is responding by lifting targets across the board. Bears are not convinced. Short interest climbed roughly 13% across the week to 12.2% of free float — a meaningful rebuild after a 10% decline over the prior month. The move puts shorts back near their mid-September high, with 32.6 million shares now borrowed against the name.
The lending market tells a nuanced story here. Availability is actually loosening, not tightening. With roughly five shares available for every one currently borrowed, the borrow pool remains well-supplied relative to the short position — a reading in the normal-to-loose range, and notably down from above 750% just ten days ago as more shares are being taken on loan. Cost to borrow is still negligible at 0.47%, up about 14% on the week but historically low in absolute terms. There is no friction in the lending market. Shorts can add positions cheaply and easily, which may partly explain why they are doing so. The ORTEX short score edged up to 49.3 from 44.7 a week ago — a steady climb that reflects the acceleration in short positioning even as the absolute level remains mid-range. Options positioning is slightly more constructive. The put/call ratio at 0.83 is actually a touch below its 20-day average of 0.85, and the z-score of -0.74 suggests options traders are less defensive than usual, not more — a notable divergence from the short-selling activity.
The Street is broadly bullish, and getting louder about it. Barclays lifted its target from $125 to $160 on September 15, maintaining an Overweight rating — a 28% upward revision from the same firm that had cut its target in early August. Canaccord lifted to $179 last week. B. Riley moved to $175 two weeks ago. Alliance Global Partners initiated at Buy with a $217 target. The consensus mean target is $225.93 against a current price of $129.60, implying roughly 74% upside as priced by the Street — though that gap partly reflects the wide dispersion in how different analysts model a company whose value is so closely tied to bitcoin. Bernstein sits at the more cautious end, having cut its target from $450 to $350 in late August while keeping an Outperform. The bull case centres on bitcoin treasury exposure and enterprise analytics stability. The bear case points to STRC preferred equity pressure, bitcoin volatility, and the structural difficulty of sustaining dividend coverage as bitcoin prices swing. The earnings momentum factor score ranks in the 97th percentile on a 30-day basis — but sits at just the 11th percentile on EPS surprise, a reminder that near-term estimates are moving up even as the company has a history of missing the actual numbers.
Institutional ownership adds another layer. Capital Research and Management held 11% as of August 31, having added 1.17 million shares. BlackRock added 1.64 million shares to reach just over 5%. Vanguard entities collectively represent another 8%+. The combined direction of travel from major passive and active managers has been to add exposure, even as the 13G/A register shows Jane Street's disclosed stake fell from 7.3% to 4.0% as of May — a move that may or may not be current given the disclosure caveat: positions are as last filed and holders dropping below 5% are not required to update.
Crypto-adjacent peers are providing no shelter. BMNR fell 8.4% on the day. CRCL dropped 11.4% on the week. BTCS shed 9.2% over the same period. Strategy's weekly loss of around 5% looks comparatively contained — but that relative resilience is being tested. The next earnings event is scheduled for October 30, and with the gap between analyst targets and the current price this wide, the next bitcoin price cycle and Strategy's BTC yield disclosures are what investors will be watching most closely before that date.
See the live data behind this article on ORTEX.
Open MSTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
